ARTICLE | Company News
Hebrew University of Jerusalem deal
June 22, 2009 7:00 AM UTC
Investment group Aurum Ventures MKI Ltd. received an option from the university's Yissum Research and Development Ltd. to license an oral reformulation of an undisclosed injectable drug that uses Yis...